In this context, our finding of reduced % transferrin saturation and elevated ceruloplasmin/transferrin ratios in CRC patients may reflect a tumor-associated shift aimed at limiting ferroptotic vulnerability [6,7,8,32,33]. The gene discussed is CP; the disease is colorectal carcinoma.